{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T12:36:38Z","timestamp":1783514198449,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.ijcard.2016.04.003","type":"journal-article","created":{"date-parts":[[2016,4,10]],"date-time":"2016-04-10T17:14:01Z","timestamp":1460308441000},"page":"493-499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Somatic symptoms of anxiety and nonadherence to statin therapy"],"prefix":"10.1016","volume":"214","author":[{"given":"Maarit Jaana","family":"Korhonen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaana","family":"Pentti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Hartikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Kivim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi","family":"Vahtera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.04.003_bb0005","series-title":"Global Status Report on Noncommunicable Diseases 2010","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.ijcard.2016.04.003_bb0010","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.04.003_bb0015","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.04.003_bb0020","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1093\/eurheartj\/eht295","article-title":"Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences","volume":"34","author":"Chowdhury","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.04.003_bb0025","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jval.2014.06.010","article-title":"Dynamic medication adherence modeling in primary prevention of cardiovascular disease: a Markov microsimulation methods application","volume":"17","author":"Slejko","year":"2014","journal-title":"Value Health"},{"key":"10.1016\/j.ijcard.2016.04.003_bb0030","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.atherosclerosis.2014.12.059","article-title":"Cost-effectiveness of statin treatment for primary prevention in conditions of real-world adherence: estimates from the Finnish prescription register","volume":"215","author":"Aarnio","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2016.04.003_bb0035","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.cjca.2012.05.007","article-title":"Proportion and risk indicators of nonadherence to statin therapy: a meta-analysis","volume":"28","author":"Lemstra","year":"2012","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.04.003_bb0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jacl.2013.09.008","article-title":"Register-based predictors of adherence among new statin users in Finland","volume":"8","author":"Aarnio","year":"2014","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.ijcard.2016.04.003_bb0045","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1345\/aph.1P150","article-title":"Predictors of nonadherence to statins: a systematic review and meta-analysis","volume":"44","author":"Mann","year":"2010","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ijcard.2016.04.003_bb0050","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.160.14.2101","article-title":"Depression is a risk factor for noncompliance with medical treatment","volume":"160","author":"DiMatteo","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2016.04.003_bb0055","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s11606-011-1704-y","article-title":"Depression and medication adherence in the treatment of chronic diseases in the United Stated: a meta-analysis","volume":"26","author":"Grenard","year":"2011","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.ijcard.2016.04.003_bb0060","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.288.4.455","article-title":"Long-term persistence in use of statin therapy in elderly patients","volume":"288","author":"Benner","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2016.04.003_bb0065","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1016\/j.clinthera.2007.12.022","article-title":"Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study","volume":"29","author":"Ye","year":"2007","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ijcard.2016.04.003_bb0070","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.acvd.2010.05.003","article-title":"Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and rehospitalization","volume":"103","author":"Tuppin","year":"2010","journal-title":"Arch. Cardiovasc. Dis."},{"key":"10.1016\/j.ijcard.2016.04.003_bb0075","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4321\/S1886-36552012000400005","article-title":"Women and men report different behaviours in, and reasons for medication non-adherence: a nationwide Swedish survey","volume":"10","author":"Thunander Sundbom","year":"2012","journal-title":"Pharm. Pract."},{"key":"10.1016\/j.ijcard.2016.04.003_bb0080","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jpsychores.2014.07.009","article-title":"Anxiety sensitivity and medication nonadherence in patients with uncontrolled hypertension","volume":"77","author":"Alcantra","year":"2014","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.ijcard.2016.04.003_bb0085","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10557-007-6040-4","article-title":"Predictors of adherence to statins for primary prevention","volume":"21","author":"Mann","year":"2007","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"1","key":"10.1016\/j.ijcard.2016.04.003_bb0090","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7812\/TPP\/09-090","article-title":"Patients' perspectives on nonadherence to statin therapy: a focus-group study","volume":"14","author":"Fung","year":"2010","journal-title":"Perm. J."},{"key":"10.1016\/j.ijcard.2016.04.003_bb0095","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jacl.2012.03.003","article-title":"Understanding statin use in America and gaps in patient education (USAGE): an internet-based survey of 10,138 current and former statin users","volume":"6","author":"Cohen","year":"2012","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.ijcard.2016.04.003_bb0100","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0165-0327(85)90050-3","article-title":"Neurovegetative symptoms in chronic pain and depression","volume":"9","author":"Davidson","year":"1985","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ijcard.2016.04.003_bb0105","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/S0140-6736(06)69865-6","article-title":"Generalised anxiety disorder","volume":"368","author":"Tyrer","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.04.003_bb0110","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1161\/CIRCULATIONAHA.115.015392","article-title":"Childhood Psychosocial Adversity and Adult Neighborhood Disadvantage as Predictors of Cardiovascular Disease: A Cohort Study","volume":"132","author":"Halonen","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.04.003_bb0115","first-page":"301537","article-title":"Liability to anxiety and severe life events as predictors of new-onset sleep disturbances","author":"Vahtera","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.ijcard.2016.04.003_bb0120","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1742-7843.2009.00494.x","article-title":"The Nordic countries as a cohort for pharmacoepidemiological research","volume":"106","author":"Furu","year":"2010","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ijcard.2016.04.003_bb0125","unstructured":"World Health Organization Collaborating Centre for Drug Statistics Methodology. Use of ATC\/DDD. Available at: http:\/\/www.whocc.no\/use_of_atc_ddd\/ (Accessed 01\/10\/2016)."},{"key":"10.1016\/j.ijcard.2016.04.003_bb0130","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00228-014-1737-3","article-title":"Measurement of statin exposure in the absence of information on prescribed doses","volume":"70","author":"Romppainen","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.04.003_bb0135","author":"National Committee for Quality Assurance"},{"key":"10.1016\/j.ijcard.2016.04.003_bb0140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ahj.2013.09.014","article-title":"Untangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes","volume":"167","author":"Choudhry","year":"2014","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2016.04.003_bb0145","author":"Peura"},{"key":"10.1016\/j.ijcard.2016.04.003_bb0150","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/bcpt.12075","article-title":"Channelling of statin use towards low-risk population and patients with diabetes","volume":"113","author":"Rikala","year":"2013","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ijcard.2016.04.003_bb0155","unstructured":"Advisory Board of Official Statistics of Finland. Official statistics of Finland: classification of education 2011, levels of education [e-publication]. Available at: http:\/\/www.stat.fi\/meta\/svt\/index_en.html (Accessed 01\/10\/2016)."},{"key":"10.1016\/j.ijcard.2016.04.003_bb0160","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1136\/bmj.319.7224.1523","article-title":"Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors","volume":"319","author":"Rimm","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2016.04.003_bb0165","series-title":"Manual for the State-trait Anxiety Inventory (STAI)","author":"Spielberger","year":"1983"},{"key":"10.1016\/j.ijcard.2016.04.003_bb0170","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1111\/j.1532-5415.2012.04239.x","article-title":"Association between depressive and anxiety disorders and adherence to antihypertensive medication in community-living elderly adults","volume":"60","author":"Gentil","year":"2012","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.ijcard.2016.04.003_bb0175","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/HJH.0b013e32836098d1","article-title":"Effect of depression onset on adherence to medication among hypertensive patients: a longitudinal modelling study","volume":"31","author":"Sj\u00f6sten","year":"2013","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ijcard.2016.04.003_bb0180","doi-asserted-by":"crossref","first-page":"e127638","DOI":"10.1371\/journal.pone.0127638","article-title":"Childhood adversity as a predictor of non-adherence to statin therapy in adulthood","volume":"10","author":"Korhonen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2016.04.003_bb0185","doi-asserted-by":"crossref","first-page":"e005402","DOI":"10.1136\/bmjopen-2014-005402","article-title":"Are statin trials in diabetes representative of real-world diabetes care: a population based study on statin initiators in Finland","volume":"4","author":"Ruokoniemi","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijcard.2016.04.003_bb0190","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ajh.2011.256","article-title":"Symptoms of depression and anxiety and adherence to antihypertensive medication","volume":"25","author":"Bautista","year":"2012","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ijcard.2016.04.003_bb0195","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jpsychores.2012.12.003","article-title":"Associations of anxious and depressive symptoms with medication nonadherence in patients with stable coronary artery disease","volume":"74","author":"Dempe","year":"2013","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.ijcard.2016.04.003_bb0200","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/PSY.0b013e3181c4e3e9","article-title":"Differences in adherence to antihypertensive medication regimens according to psychiatric diagnosis: Results from a Korean population-based study","volume":"72","author":"Kim","year":"2010","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.ijcard.2016.04.003_bb0205","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00228-005-0980-z","article-title":"Persistence and determinants of statin therapy among middle-aged patients free of cardiovascular disease","volume":"61","author":"Perreault","year":"2005","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.04.003_bb0210","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1365-2125.2005.02355.x","article-title":"Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention","volume":"59","author":"Perreault","year":"2005","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2016.04.003_bb0215","first-page":"374","article-title":"Why cardiac patients discontinued lipid lowering agents: views on gastrointestinal adverse reactions and their risk factors","volume":"4","author":"Abdulrazzaq","year":"2012","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ijcard.2016.04.003_bb0220","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1017\/S0033291796004242","article-title":"The validity of two versions of the GHQ in the WHO study of mental illness in general health care","volume":"27","author":"Goldberg","year":"1997","journal-title":"Psychol. Med."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316306787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316306787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T12:56:57Z","timestamp":1536843417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316306787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":44,"alternative-id":["S0167527316306787"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.04.003","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Somatic symptoms of anxiety and nonadherence to statin therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}